MT-202 ATAK cell vaccine (Myeloid Therapeutics/Duke University)

N/A

Report date: 2025/01/26 15:46:07

Base Information

Drug NameMT-202 ATAK cell vaccine (Myeloid Therapeutics/Duke University)
Drug Alias NameMT-202 ATAK Vaccine (Myeloid Therapeutics/Duke University)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDuke University
China Registration ClassN/A

Develop Information

Active CompaniesDuke UniversityMyeloid Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A